Research Update: Welch Foods Inc. Outlook Revised To Negative On Expectation Of Weaker Credit Measures; 'A-' Rating Affirmed Jan 13

  • ID: 2383439
  • January 2013
  • Standard & Poors
1 of 3

We believe a small 2012 Concord grape harvest will result in lower patron earnings and weaker credit measures for Welch Foods Inc. in fiscal 2013. We are affirming all our ratings on the company, including the 'A-' corporate credit rating. We are revising the outlook to negative, reflecting our concerns that credit measures may remain weaker than our expectations for the current ratings over next 12 to 24 months. On Jan. 24, 2013, Standard & Poor's Ratings Services affirmed all its ratings on Concord, Mass.-based Welch Foods Inc., including the 'A-' corporate credit rating. At the same time, we revised the outlook to negative. Welch foods had about $135 million in reported debt outstanding as of Dec. 2, 2012. The...

Companies mentioned in this report are:
- Welch Foods Inc.

Action: Affirmed
Action: Outlook: Negative

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Product Type: Research Update
Research updates complement media releases. They offer more depth and detail than summary analyses by incorporating all information published in the media release. They are more up to date than summaries in that they are published simultaneously with media releases.

Note: Product cover images may vary from those shown
2 of 3

- Welch Foods Inc.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.